Serum digitalis measurements in the assessment of digitalis resistance and sensitivity (Q33988302)

30 July 2017

1 reference

title

Serum digitalis measurements in the assessment of digitalis resistance and sensitivity (English)

1 reference

30 July 2017

Butler VP Jr

1

1 reference

30 July 2017

V. P. Butler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1092161

21 August 2022

J. Lindenbaum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1092161

21 August 2022

language of work or name

English

0 references

publication date

1 April 1975

1 reference

full work available at URL

30 July 2017

https://api.elsevier.com/content/article/PII:0002934375901175?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

https://api.elsevier.com/content/article/PII:0002934375901175?httpAccept=text/plain

13 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

American Journal of Medicine

13 September 2023

published in

1 reference

30 July 2017

volume

58

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

460-469

1 reference

Resistance and sensitivity to digitalis

30 July 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The clinical pharmacology of digitalis glycosides: a review

13 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digitalis glycosides. Pharmacokinetics and their clinical implications

13 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digitalis pharmacokinetics and metabolism

13 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The measurement of digitoxin in human serum by radioimmunoassay

13 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

13 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Assays of digitalis in the blood

13 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Contribution of quantitative assay technics to the understanding of the clinical pharmacology of digitalis

13 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digitalis (third of four parts).

13 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digitalis toxicity: Epidemiology and clinical use of serum concentration measurements

13 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Variation in Biologic Availability of Digoxin from Four Preparations

13 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Variation in the biological availability of digoxin

13 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Bioavailability of digoxin tablets

13 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Biological availability of digoxin from Lanoxin produced in the United Kingdom.

13 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets

13 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin tablet bioavailability: single-dose and steady-state assessment

13 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma Concentrations of Digoxin after Oral Administration in the Fasting and Postprandial State

13 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Absorption of Digoxin in Patients with Malabsorption Syndromes

13 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The Absorption of Orally Administered [12α-3H]Digoxin in Man

13 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Evaluation of Digoxin Bioavailability in Single-Dose Studies

13 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Pharmacokinetics of Digoxin: Interpreting Bioavailability

13 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes

13 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The gastrointestinal absorption of digoxin in seven patients with gastric or small intestinal reconstructions

13 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Unusually large digitalis requirements. A study of altered digoxin metabolism

13 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Interactions between digitoxin and other drugs in vitro and in vivo

13 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Interactions between digitoxin and other drugs in man

13 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE

13 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The metabolism of tritiated digoxin in renal insufficiency in dogs and man

13 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Relationship of the excretion of tritiated digoxin to renal function

13 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin Metabolism in the Elderly

13 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Effects of Renal Function on Plasma Digoxin Levels in Elderly Ambulant Patients in Domiciliary Practice

13 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis

13 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin-specific antibodies

13 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin: immunologic approaches to measurement and reversal of toxicity

13 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin

13 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay

13 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma Concentration and Urinary Excretion Kinetics of Acetyl Strophanthidin

13 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Characterization and specificity of proscillaridin antibodies

13 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration

13 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digitalis intoxication. A prospective clinical study with serum level correlations

13 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma digoxin concentrations and digoxin toxicity in hospital patients

13 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Serum digoxin by radioimmunoassay

13 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The radioimmunoassay of plasma-digoxin

13 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

An improved method for measuring plasma and tissue concentrations of digitalis glycosides

13 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug

13 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

The enzymatic assay of plasma digoxin

13 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Assay of digoxin in plasma by gas chromatography

13 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Serum cardiac glycoside assay based upon displacement of 3 H-ouabain from Na-K ATPase

13 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma Digoxin Concentrations in Patients with Atrial Fibrillation

13 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation

13 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

THE USE OF DIGITALIS IN INFANTS AND CHILDREN.

13 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Drug therapy of heart disease in pediatric patients. II. The treatment of congestive heart failure in infants and children with digitalis preparations

13 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Serum Digoxin Concentrations in the Human Fetus, Neonate and Infant

13 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Tritiated digoxin. 18. Studies in infants and children

13 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Plasma digoxin levels in infants

13 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

13 September 2023

69

2

1971

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Bioavailability of Digoxin

13 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Letter: Inequal digoxin tablets

13 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Correlation of digoxin-tablet dissolution-rate with biological availability.

13 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Rate of dissolution of digoxin tablets as a predictor of absorption

13 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Dissolution and bioavailability of digoxin tablets

13 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Therapeutic Non-equivalence of Digoxin Tablets in United Kingdom: Correlation with Tablet Dissolution Rate

13 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Particle size and absorption of digoxin

13 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Symposium on pharmacologic and clinical control of cardiovascular drugs. Comments from the Food and Drug Administration

13 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Editorial: Digoxin--the regulatory viewpoint

13 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Editorial: What the practicing physician should know about digoxin bioavailability and how will FDA action affect him?

13 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Treatment of digoxin intoxication.

13 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Altered absorption of digoxin in patients given propantheline and metoclopramide

13 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action

13 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Death from weight-control pills. A case report with objective postmortem confirmation

13 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Large-scale digitoxin intoxication.

13 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.

13 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

Serum concentration and urinary excretion of 3 H-ouabain and 3 H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism

13 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0002-9343(75)90117-5

13 September 2023

Identifiers

1 reference

30 July 2017

1 reference